Clinical Trials at START Mountain Region
As of September 2026, 40 paid clinical trials are recruiting at START Mountain Region in West Valley City, Utah. Active studies at this site cover conditions such as Advanced Solid Tumor, Colorectal Cancer and Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in West Valley City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
41 clinical trials at START Mountain Region
·Clear filters·Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
A Study of LY4175408 in Participants With Advanced Cancer
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
A Study of MGC026 in Participants With Advanced Solid Tumors
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Common conditions studied in West Valley City
- Advanced Solid Tumor (9 active studies)
- Colorectal Cancer (7 active studies)
- Solid Tumor (7 active studies)
- Ovarian Cancer (6 active studies)
- Triple Negative Breast Cancer (6 active studies)
- Breast Cancer (5 active studies)
Leading research sponsors in West Valley City
- Eli Lilly and Company
- AbbVie
- GlaxoSmithKline
- IDEAYA Biosciences
- Biohaven Therapeutics Ltd.
Frequently asked questions
How many paid clinical trials are currently recruiting in West Valley City?
There are approximately 79 recruiting clinical trials in West Valley City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in West Valley City pay participants?
Most recruiting trials in West Valley City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in West Valley City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in West Valley City?
The most common conditions under active study in West Valley City include Advanced Solid Tumor (9), Colorectal Cancer (7), Solid Tumor (7), Ovarian Cancer (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in West Valley City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in West Valley City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in West Valley City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in West Valley City?
Recruiting research sites in West Valley City include START Mountain Region, START Mountain Region, LLC, GSK Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in West Valley City right now?
The largest active categories in West Valley City are Cancer & tumors (57), Neurology & pain (3), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.